Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

sections

    Cancer

    The latest learning and CPD content on cancer. Under ‘Other resources’ you will find all our other content related to cancer.

    CPD and Learning

    chemotherapy patient ss 17

    Cancer-associated thrombosisSubscription

    8 SEP 2020By ,

    Venous thromboembolism is a complication of cancer that pharmacists should understand to ensure that their patients have the best possible outcomes.  

    Improving oral health: preventative care messages in community pharmacy

    Improving oral health: preventative care messages in community pharmacySubscription

    5 FEB 2020By ,

    Dental caries, periodontal disease and oral cancer are health problems that can be prevented with the help of community pharmacists.

    Light micrograph of blood cells from bone marrow in a case of acute leukaemia

    Treatment of acute and chronic lymphoid leukaemiaSubscription

    21 JAN 2020By ,

    Pharmacists should be able to describe the differences between acute lymphoblastic and chronic lymphocytic leukaemia and the available treatment.

    Colorectal cancer fecal tests

    Colorectal cancer screening and the role of community pharmacySubscription

    23 JAN 2019By , , , , ,

    Access to colorectal cancer screening varies across the UK. This article describes the various tests and how community pharmacists can promote them.

    Pharmacist giving out medication in cancer awareness paper bag

    Identifying patients with suspected cancer: red flags and referral Subscription

    16 OCT 2018By

    This article provides practical advice to support pharmacy professionals in their duty of care to recognise and refer patients with ‘red flag’ cancer symptoms.

    SEM of tumour in lung

    Lung cancer: advances in management and therapySubscription

    7 JUN 2018By ,

    An overview of traditional and emerging immunotherapy-based targets and treatments available for lung cancer, their side effects and the impact immune checkpoint inhibitors have had on the treatment of non–small-cell lung cancer.

    Illustration of T cells attacking cancer cells

    Immune checkpoint inhibitors in cancer: pharmacology and toxicitiesSubscription

    22 MAY 2018By ,

    These treatments are commonly associated with autoimmune-related side effects and toxicities. This article outlines how pharmacists and the pharmacy team can recognise and manage these adverse events.

    Other resources

    Vitamin D

    Vitamin D may protect against colitis adverse events in patients taking immune checkpoint inhibitorsSubscription

    14 JUL 2020

    People with melanoma who take immune checkpoint inhibitors are less likely to develop colitis if they are taking vitamin D supplements at treatment initiation, a study published in the journal Cancer has suggested

    Antibodies attacking cancer cell

    Immuno-oncology agents for cancer therapySubscription

    7 MAY 2020By ,

    Abstract: Until recently, cancer therapy comprised of four main types of treatment: surgery, radiotherapy, chemotherapy and targeted therapy. Over the past decade, immuno-oncology (IO) has emerged as a novel and important approach to cancer treatment through the stimulation of the body’s own immune system to kill cancer cells. This newly recognised method of treating cancer is rapidly developing, with many accelerated approvals by the US Food and Drug Administration and European Medicines ...

    Colon cancer endoscope image

    Lower-GI bleeding should be investigated in anticoagulated patients, researchers saySubscription

    20 MAR 2020

    Lower gastrointestinal bleeding in patients with atrial fibrillation who are being treated with oral anticoagulants is associated with a higher risk of being diagnosed with colorectal cancer, a study published in the European Heart Journal suggests.

    Going against type  the new class of cancer therapies targeting mutations rather than tissues

    Going against type: the new class of cancer therapies targeting mutations rather than tissuesSubscription

    19 MAR 2020By

    ‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?

    statin tablets put of pill box

    Statins could be linked to reduced risk of ovarian cancer, researchers findSubscription

    5 MAR 2020

    Women who take statins long-term, including those carrying the BRCA1/2 gene mutation, could be less likely to develop ovarian cancer than those who do not, research published in JAMA has suggested.

    Woman undergoing radiotherapy

    Step counting can help predict outcomes for patients undergoing lung cancer treatment Subscription

    11 FEB 2020By

    Measuring patients’ step counts before they receive lung cancer treatment could help predict outcomes, research published in the International Journal of Radiation Oncology, Biology, Physics has suggested.

    Trials of HPV vaccine may have overestimated its efficacy study finds

    Trials of HPV vaccine may have overestimated its efficacy, study findsSubscription

    4 FEB 2020

    The efficacy of human papillomavirus vaccines as a preventative for cervical cancer may have been overestimated in trials, a review in the Journal of the Royal Society of Medicine has concluded.

    Melanoma on skin

    Combination immunotherapy for melanoma improves long-term survival ratesSubscription

    21 NOV 2019

    Patients with advanced melanoma treated with a combination of ipilimumab and nivolumab are more likely to be alive five years later than patients treated with ipilimumab alone or nivolumab alone.

    Revalidation

    Pharmacists and pharmacy technicians can find guidance from The Pharmaceutical Journal on completing the relevant records to meet the General Pharmaceutical Council requirements, as well as support on the scope of activity that could be included in these records here.